Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience.

Link to article at PubMed

Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience.

Int J Cardiol. 2012 Feb 24;

Authors: De Luca G, Verdoia M, Binda G, Schaffer A, Suryapranata H, Marino P

Abstract
INTRODUCTION: Dual antiplatelet therapy (aspirin and ADP-antagonists) is mandatory after stent implantation in order to avoid stent thrombosis, especially in the era of DES. In fact, a delayed re-endothelization process may enlarge the window of occurrence of stent thrombosis beyond 1-year after implantation. Allergy to acid acetylsalicylic is not a rare event and may influence the use and the choice of coronary stent with an important impact in terms of outcome especially in patients at high risk for in-stent restenosis. The aim of this study was to evaluate the safety and efficacy of a new intravenous rapid desensitization protocol in patients with acetylsalicylic acid sensitivity undergoing coronary stent implantation. METHODS: Among a total of 1385 patients undergoing coronary angioplasty at our catheterization laboratory from January 2007 to June 2011, a total of 43 patients (3.1%) had history of aspirin sensitivity characterized by respiratory or cutaneous manifestations (none had previous anaphylactic reactions). Twenty-three patients (53.5%) presented with acute coronary syndromes. All patients underwent a novel rapid desensitization procedure before or after cardiac catheterization (in case of ST-elevation myocardial infarctions, n=5). The desensitization procedure was based on intravenous administration of 9 sequential doses of aspirin (1, 2, 4, 8, 16, 32, 64, 128, 250mg) over 4.5h without the use of corticosteroids or antihistamines. Patients were followed for at least 30days and up to 12months to assess compliance with aspirin therapy and adverse events. RESULTS: The desensitization procedure was successful in 42 patients (97.6%). All patients underwent stent implantation (1.6 stents/patient). Drug-eluting stents were used in 36 patients (85.7%). At follow-up, all patients who successfully responded to the desensitization procedure did not develop any allergic reaction. CONCLUSIONS: This study showed the safety and efficacy of a new rapid intravenous protocol desensitization for patients with history of aspirin sensitivity undergoing planned or urgent coronary stent implantation.

PMID: 22365313 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.